Literature DB >> 20559144

Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression.

F Andrew Kozel1, Kevin A Johnson, Ziad Nahas, Paul A Nakonezny, Paul S Morgan, Berry S Anderson, Samet Kose, Xingbao Li, Kelvin O Lim, Madhukar H Trivedi, Mark S George.   

Abstract

OBJECTIVES: As part of a sham controlled treatment trial using daily left repetitive transcranial magnetic stimulation (rTMS), brain changes associated with 4 to 6 weeks of treatment were examined using diffusion tensor imaging to noninvasively evaluate prefrontal white matter (WM) microstructure. A decrease in fractional anisotropy values of the left prefrontal WM could indicate damage to the region.
METHODS: Diffusion tensor imaging was performed before and after 4 to 6 weeks of daily rTMS treatments. Mean fractional anisotropy levels associated with active rTMS and sham rTMS for the right and left prefrontal WM were assessed.
RESULTS: Adequate images were acquired for 8 participants (active n = 4, sham n = 4) before and after rTMS. A mean increase was found for the left prefrontal WM. The mixed model revealed a trend toward a significant treatment group × region interaction effect (P = 0.11). Furthermore, simple region effects (left prefrontal WM vs right prefrontal WM) were at a trend toward significance for difference after treatment within the active rTMS group (P = 0.07), but not within the sham rTMS group (P = 0.88).
CONCLUSIONS: Repetitive transcranial magnetic stimulation resulted in no evidence of damage to WM on the side of stimulation. Diffusion tensor imaging may offer a unique modality to increase our understanding of mechanisms of action for rTMS.

Entities:  

Mesh:

Year:  2011        PMID: 20559144      PMCID: PMC2975808          DOI: 10.1097/YCT.0b013e3181e6317d

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  46 in total

1.  Lack of significant changes on magnetic resonance scans before and after 2 weeks of daily left prefrontal repetitive transcranial magnetic stimulation for depression.

Authors:  Z Nahas; C DeBrux; V Chandler; J P Lorberbaum; A M Speer; M A Molloy; C Liberatos; S C Risch; M S George
Journal:  J ECT       Date:  2000-12       Impact factor: 3.635

2.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

Review 3.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

4.  Effect of chronic repetitive transcranial magnetic stimulation on regional cerebral blood flow and regional cerebral glucose uptake in drug treatment-resistant depressives. A brief report.

Authors:  Andreas Conca; William Peschina; Peter König; Heinz Fritzsche; Armand Hausmann
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

5.  A simplified method to measure the diffusion tensor from seven MR images.

Authors:  P J Basser; C Pierpaoli
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

6.  Neuropsychiatric applications of DTI - a review.

Authors:  K O Lim; J A Helpern
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

7.  Diffusion tensor imaging in schizophrenia.

Authors:  Monte S Buchsbaum; Joseph Friedman; Bradley R Buchsbaum; King-Wai Chu; Erin A Hazlett; Randall Newmark; Jason S Schneiderman; Yuliya Torosjan; Cheuk Tang; Patrick R Hof; Daniel Stewart; Kenneth L Davis; Jack Gorman
Journal:  Biol Psychiatry       Date:  2006-08-07       Impact factor: 13.382

8.  Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients.

Authors:  Felix M Mottaghy; Christian E Keller; Massimo Gangitano; Jennifer Ly; Mark Thall; J Anthony Parker; Alvaro Pascual-Leone
Journal:  Psychiatry Res       Date:  2002-08-20       Impact factor: 3.222

9.  High (15 Hz) and low (1 Hz) frequency transcranial magnetic stimulation have different acute effects on regional cerebral blood flow in depressed patients.

Authors:  C K Loo; P S Sachdev; W Haindl; W Wen; P B Mitchell; V M Croker; G S Malhi
Journal:  Psychol Med       Date:  2003-08       Impact factor: 7.723

10.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

View more
  15 in total

Review 1.  Neuroimaging in psychiatric disorders.

Authors:  Joseph C Masdeu
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 2.  Beyond neural cubism: promoting a multidimensional view of brain disorders by enhancing the integration of neurology and psychiatry in education.

Authors:  Joseph J Taylor; Nolan R Williams; Mark S George
Journal:  Acad Med       Date:  2015-05       Impact factor: 6.893

Review 3.  Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging.

Authors:  Jing Jiang; You-Jin Zhao; Xin-Yu Hu; Ming-Ying Du; Zi-Qi Chen; Min Wu; Kai-Ming Li; Hong-Yan Zhu; Poornima Kumar; Qi-Yong Gong
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

Review 4.  Neuroimaging Mechanisms of Therapeutic Transcranial Magnetic Stimulation for Major Depressive Disorder.

Authors:  Noah S Philip; Jennifer Barredo; Emily Aiken; Linda L Carpenter
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-11-11

Review 5.  Biological markers in noninvasive brain stimulation trials in major depressive disorder: a systematic review.

Authors:  Thiago M Fidalgo; J Leon Morales-Quezada; Guilherme S C Muzy; Noelle M Chiavetta; Mariana E Mendonca; Marcus V B Santana; Oscar F Goncalves; Andre R Brunoni; Felipe Fregni
Journal:  J ECT       Date:  2014-03       Impact factor: 3.635

6.  White matter markers and predictors for subject-specific rTMS response in major depressive disorder.

Authors:  Lipeng Ning; Yogesh Rathi; Tracy Barbour; Nikos Makris; Joan A Camprodon
Journal:  J Affect Disord       Date:  2021-12-04       Impact factor: 6.533

7.  More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013.

Authors:  Karina Karolina Kedzior; Valeriya Azorina; Sarah Kim Reitz
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-07       Impact factor: 2.570

Review 8.  Transcranial magnetic stimulation: potential treatment for co-occurring alcohol, traumatic brain injury and posttraumatic stress disorders.

Authors:  Amy A Herrold; Sandra L Kletzel; Brett C Harton; R Andrew Chambers; Neil Jordan; Theresa Louise-Bender Pape
Journal:  Neural Regen Res       Date:  2014-10-01       Impact factor: 5.135

9.  Repetitive transcranial magnetic stimulation for depression after basal ganglia ischaemic stroke: protocol for a multicentre randomised double-blind placebo-controlled trial.

Authors:  Ying Tang; Aimin Chen; Shuzhen Zhu; Li Yang; Jiyuan Zhou; Suyue Pan; Min Shao; Lianxu Zhao
Journal:  BMJ Open       Date:  2018-02-03       Impact factor: 2.692

10.  Improvement Of Frontal Lobe Dysfunction And White Matter Integrity By rTMS In Treatment-Resistant Depression.

Authors:  Hiroshi Tateishi; Masashi Nishihara; Atsushi Kawaguchi; Jun Matsushima; Toru Murakawa; Yoshinori Haraguchi; Yutaka Kunitake; Toshihiko Maekawa; Takahiro A Kato; Toyoko Asami; Yoshito Mizoguchi; Akira Monji
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.